Regulation & governance

Eli Lilly’s retatrutide could reset obesity care, but rising demand and grey-market access are testing regulators and health systems

Metabolic health is no longer just a clinic problem. It is a city, climate and equity problem

AMR Stewardship Starts Before the Antibiotic Is Prescribed

A Rare Pain Disorder Gets a Pivotal Trial

Soft-Cheese Listeria Outbreak Shows Food Safety Is Patient Safety

World Cup Health Guidance Turns Football Into a Public-Health Test

What happens when surgeons no longer need to be in the same country as their patients?

As GLP-1 use expands, healthcare systems are confronting a new challenge: balancing obesity treatment with rising concerns about eating disorders and patient safety.

GSK’s Nuvalent Deal Turns Lung Cancer Precision Into a $10.6 Billion Access Race
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
